These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25691086)

  • 1. The neoadjuvant treatment of rectal cancer: a review.
    Nussbaum N; Altomare I
    Curr Oncol Rep; 2015 Mar; 17(3):434. PubMed ID: 25691086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal cancer: An evidence-based update for primary care providers.
    Gaertner WB; Kwaan MR; Madoff RD; Melton GB
    World J Gastroenterol; 2015 Jul; 21(25):7659-71. PubMed ID: 26167068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape?
    Lee M; Gibbs P; Wong R
    Clin Colorectal Cancer; 2015 Dec; 14(4):251-61. PubMed ID: 26210575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total neoadjuvant therapy for rectal cancer: An emerging option.
    Ludmir EB; Palta M; Willett CG; Czito BG
    Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064).
    Hüttner FJ; Probst P; Kalkum E; Hackbusch M; Jensen K; Ulrich A; Büchler MW; Diener MK
    Syst Rev; 2018 Jan; 7(1):11. PubMed ID: 29357929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in multidisciplinary approach for rectal cancer.
    Oki E; Ando K; Kasagi Y; Zaitsu Y; Sugiyama M; Nakashima Y; Sonoda H; Ohgaki K; Saeki H; Maehara Y
    Int J Clin Oncol; 2015 Aug; 20(4):641-9. PubMed ID: 26100273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant Combined-Modality Therapy for Locally Advanced Rectal Cancer and Its Future Direction.
    Salem ME; Hartley M; Unger K; Marshall JL
    Oncology (Williston Park); 2016 Jun; 30(6):546-62. PubMed ID: 27306709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal cancer: Neoadjuvant chemoradiotherapy.
    Rödel C; Hofheinz R; Fokas E
    Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):629-39. PubMed ID: 27644910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen.
    Habr-Gama A; Perez RO; São Julião GP; Proscurshim I; Fernandez LM; Figueiredo MN; Gama-Rodrigues J; Buchpiguel CA
    Radiat Oncol; 2016 Feb; 11():24. PubMed ID: 26911200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Neoadjuvant Treatment for Rectal Cancer: The Brown University Oncology Group CONTRE Study.
    Perez K; Safran H; Sikov W; Vrees M; Klipfel A; Shah N; Schechter S; Oldenburg N; Pricolo V; Rosati K; Dipetrillo T
    Am J Clin Oncol; 2017 Jun; 40(3):283-287. PubMed ID: 25374145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.
    Kripp M; Wieneke J; Kienle P; Welzel G; Brade J; Horisberger K; Wenz F; Post S; Gencer D; Hofmann WK; Hofheinz RD
    Eur J Surg Oncol; 2012 Jun; 38(6):472-7. PubMed ID: 22349986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Preoperative Chemoradiotherapy and Combined Chemotherapy with Radiotherapy Without Surgery for Locally Advanced Rectal Cancer.
    Supaadirek C; Pesee M; Thamronganantasakul K; Thalangsri P; Krusun S; Supakalin N
    Asian Pac J Cancer Prev; 2016; 17(7):3511-4. PubMed ID: 27510001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer.
    Huh JW; Kim HR; Kim YJ
    Dis Colon Rectum; 2013 Jun; 56(6):698-703. PubMed ID: 23652742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.
    García-Albéniz X; Gallego R; Hofheinz RD; Fernández-Esparrach G; Ayuso-Colella JR; Bombí JA; Conill C; Cuatrecasas M; Delgado S; Ginés A; Miquel R; Pagés M; Pineda E; Pereira V; Sosa A; Reig O; Victoria I; Feliz L; María de Lacy A; Castells A; Burkholder I; Hochhaus A; Maurel J
    World J Gastroenterol; 2014 Nov; 20(42):15820-9. PubMed ID: 25400468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant and adjuvant therapy for rectal cancer.
    Arnoletti JP; Bland KI
    Surg Oncol Clin N Am; 2006 Jan; 15(1):147-57. PubMed ID: 16389155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.